Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01061749 | Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02096341 | A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 | terminated | Phase 1 | 2 | EpicentRx, Inc.INDUSTRY | 1 | Jan 21, 2016 | clinicaltrials |
| NCT00008125 |
| Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors |
| completed |
| Phase 1 |
| 25 |
| University of PittsburghOTHER |
| 1 |
| Jan 15, 2016 |
| clinicaltrials |
| NCT01093092 | Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | terminated | Phase 1 | 14 | Roswell Park Cancer InstituteOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02533895 | Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood | completed | Phase 1 | 67 | Activartis BiotechINDUSTRY | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00110357 | Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors | completed | Phase 1 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT01694472 | Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors | unknown | Phase 1 | 15 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT00014378 | Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT01056029 | Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | GenSpera, Inc.INDUSTRY | 1 | Dec 10, 2015 | clinicaltrials |
| NCT01809912 | Safety Study of MG1102 in Patients With Solid Tumors | terminated | Phase 1 | 16 | Green Cross CorporationINDUSTRY | 1 | Nov 26, 2015 | clinicaltrials |
| NCT01004822 | A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors | terminated | Phase 1 | 31 | PfizerINDUSTRY | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02056392 | To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | completed | Phase 1 | 54 | AstraZenecaINDUSTRY | 1 | Nov 9, 2015 | clinicaltrials |
| NCT00547547 | High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 22 | City of Hope Medical CenterOTHER | 1 | Nov 6, 2015 | clinicaltrials |
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00877474 | Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | PharmaMarINDUSTRY | 2 | Nov 4, 2015 | clinicaltrials |
| NCT01245543 | Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Daiichi SankyoINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT01299636 | Study of PM060184 in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | PharmaMarINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT01293630 | A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00932126 | This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors | terminated | Phase 1 | 35 | PfizerINDUSTRY | 2 | Oct 28, 2015 | clinicaltrials |
| NCT01625156 | Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery | completed | Phase 1 | 11 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00557856 | A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | PfizerINDUSTRY | 3 | Oct 19, 2015 | clinicaltrials |
| NCT01100931 | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | completed | Phase 1 / Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2015 | clinicaltrials |
| NCT01128998 | Sorafenib Plus S-1 in Advanced Solid Tumors | completed | Phase 1 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT00550017 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) | terminated | Phase 1 / Phase 2 | 39 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00884676 | Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 36 | Jaime MerchanOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Genentech, Inc.INDUSTRY | 0 | Oct 8, 2015 | clinicaltrials |
| NCT02462707 | A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Oct 7, 2015 | clinicaltrials |
| NCT01039155 | Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01548482 | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00770536 | AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR | completed | Phase 1 | 103 | AmgenINDUSTRY | 3 | Sep 29, 2015 | clinicaltrials |
| NCT01317927 | A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies | completed | Phase 1 | 27 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02525536 | A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors | completed | Phase 1 | 18 | TakedaINDUSTRY | 0 | Sep 22, 2015 | clinicaltrials |
| NCT01560325 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 21 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Sep 16, 2015 | clinicaltrials |
| NCT00598091 | A Phase I/Expansion Study of Dasatinib(Gem/Dsat) | terminated | Phase 1 | 30 | Duke UniversityOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT01071018 | A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007) | completed | Phase 1 | 24 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 7, 2015 | clinicaltrials |
| NCT02263950 | A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours(LON002-002) | unknown | Phase 1 / Phase 2 | 87 | LondonPharma Ltd.INDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 2 | Sep 1, 2015 | clinicaltrials |
| NCT01553656 | Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer | completed | Phase 1 | 85 | ExelixisINDUSTRY | 1 | Aug 20, 2015 | clinicaltrials |
| NCT02395068 | Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors | unknown | Phase 1 | 40 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT02300467 | NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors | unknown | Phase 1 | 30 | National OncoVentureOTHER | 1 | Aug 14, 2015 | clinicaltrials |
| NCT00121277 | Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 28 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00126620 | Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 17 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01163903 | Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours | completed | Phase 1 | 24 | University Health Network, TorontoOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02496949 | A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors | completed | Phase 1 | 28 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT00413075 | Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 121 | Valerio TherapeuticsINDUSTRY | 3 | Jul 8, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jan 25, 2016source: clinicaltrials